2023
DOI: 10.7759/cureus.35086
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacotherapy in Tobacco Cessation: A Narrative Review

Abstract: A chronic, recurring illness, known as nicotine addiction and dependence, is defined by a person's dependence on the substance up to the extent that their normal day-to-day activities are compromised in the absence of the substance. This paper will highlight first-line smoking cessation treatments, such as nicotine replacement therapy (NRT), bupropion, and varenicline, and second-line medications, such as clonidine, nortriptyline, anxiolytics, mecamylamine, naltrexone, and NicVAX (Nabi Biopharmaceuticals, Rock… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…Surveys also indicate many e-cigarette users eventually discontinue vaping as well. More research is needed on long-term trajectories of e-cigarette use and correlations with permanently quitting smoking (Pajai et al 2023). Given the limited long-term efficacy of existing approaches, investigation into the potential role of electronic cigarettes as cessation devices has intensified over the past decade.…”
Section: Smoking Cessationmentioning
confidence: 99%
“…Surveys also indicate many e-cigarette users eventually discontinue vaping as well. More research is needed on long-term trajectories of e-cigarette use and correlations with permanently quitting smoking (Pajai et al 2023). Given the limited long-term efficacy of existing approaches, investigation into the potential role of electronic cigarettes as cessation devices has intensified over the past decade.…”
Section: Smoking Cessationmentioning
confidence: 99%
“…2 The impact of public health policies has been increased by the development and implementation of diverse pharmacological therapies to support smoking cessation, including a variety of nicotine replacement products. 3 …”
Section: Introductionmentioning
confidence: 99%